Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FJ5KX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $40,909
Award facts
- Contract value 100% obligated
- $40,909.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $40,909.18 to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300 mg pen injections (2 mL) under a firm fixed-price contract. The award was made on September 26, 2025, with an ultimate completion date of September 29, 2025, and does not carry a set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp serves as a prime pharmaceutical distributor for federal medical procurement, supplying brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to military and veteran healthcare systems. The company has demonstrated capability to meet federal procurement requirements through competitive awards across multiple therapeutic domains. The SPE2DX contract functions as a comprehensive global pharmaceutical support vehicle enabling the supply of pharmaceutical products and medical supplies to support military healthcare programs worldwide, with the DLA Troop Support planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts involving multiple regional awards.
Quick answers
Who was awarded contract SPE2DB25FJ5KX?
SPE2DB25FJ5KX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 26, 2025.
How much is contract SPE2DB25FJ5KX worth?
The government has obligated $40,909 on SPE2DB25FJ5KX.
Is contract SPE2DB25FJ5KX an order under another contract?
Yes. SPE2DB25FJ5KX is a delivery order under SPE2DB22D2007, an indefinite delivery contract.
Was contract SPE2DB25FJ5KX competed?
The extent of competition for SPE2DB25FJ5KX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award